ℹ️ Compiled from public regulatory records · Last regulator revision: May 29, 2026🚩 Report this page

Perindopril

Ace Inhibitors, Plain

GB MHRACA Health Canada

Drug class: Ace Inhibitors, Plain
Availability: See label
Routes: Oral
Markets covered: 2
Products on record: 43

Overview

Perindopril is an active pharmaceutical ingredient in the Ace Inhibitors, Plain group (C09AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	34	May 29, 2026
CA Canada	Health Canada	9	November 27, 2025

GBUnited Kingdom· MHRA

34 products

Uses

GBOfficial regulatory label· revised December 19, 2025[1]

Hypertension:
Treatment of hypertension.
Heart failure:
Treatment of symptomatic heart failure.
Stable coronary artery disease:
Reduction of risk of cardiac events in patients with a history of myocardial infarction and/or revascularisation.

How to take

CACanada· Health Canada

9 products

Uses

CAOfficial regulatory label· revised November 27, 2025[2]

PERINDOPRIL ERBUMINE (perindopril erbumine) is indicated for: • Hypertension o The treatment of mild to moderate essential hypertension. It may be used alone or in association with other drugs, particularly thiazide diuretics. o The safety and efficacy of PERINDOPRIL ERBUMINE in renovascular hypertension have not been established and therefore, its use in this condition is not recommended.
o The safety and efficacy of concurrent use of PERINDOPRIL ERBUMINE with antihypertensive agents, other than amlodipine and thiazide diuretics, have not been established. • Congestive Heart Failure o The treatment of mild to moderate congestive heart failure, generally as adjunctive therapy to diuretics, and where appropriate a digitalis glycoside.
Treatment should be initiated under close medical supervision. The safety and efficacy of PERINDOPRIL ERBUMINE have not been demonstrated for New York Heart Association Category IV patients. • Hypertensive and/or post-MI patients with stable coronary artery disease.

Drug interactions

Known interactions involving Perindopril. Select one for details. This list is informational and not a complete interaction checker.

Aliskiren Allopurinol Amiloride Azilsartan Eprosartan Irbesartan Leflunomide Lithium Carbonate Lomitapide Losartan Mipomersen Olmesartan Pexidartinib Potassium Acetate Potassium Bicarbonate Potassium Chloride Potassium Citrate Potassium Gluconate Potassium Iodide Spironolactone Telmisartan Teriflunomide Tizanidine Triamterene Trimethoprim Valsartan Acetazolamide Acetohexamide Aldesleukin Alfentanil Alfuzosin Alogliptin Alprazolam Alteplase Amifostine Amisulpride Amitriptyline Amoxapine Angiotensin II Anistreplase Apomorphine Apraclonidine Aripiprazole Asenapine Asparaginase Aspirin Aurothioglucose Avanafil Azathioprine Baclofen Bedaquiline Bendroflumethiazide Benzhydrocodone Benzthiazide Betamethasone Brentuximab Vedotin Brexpiprazole Brimonidine Bromfenac Bromotheophylline Budesonide Bumetanide Buprenorphine Bupropion Buspirone Butabarbital Butorphanol Cabergoline Calaspargase Pegol Canagliflozin Cannabidiol Cariprazine Carisoprodol Celecoxib Chlordiazepoxide Chlorothiazide Chlorpromazine Chlorpropamide Chlorthalidone Clobazam Clofarabine Clomipramine Clonazepam Clorazepate Clozapine Codeine Corticotropin Cosyntropin Cyclosporine Dalteparin Dapagliflozin Deflazacort Dexamethasone Dexmedetomidine Diazepam Diclofenac Diflunisal Digoxin Dihydrocodeine Dimenhydrinate Diphenhydramine Doxazosin Doxepin Dronabinol Drospirenone Efavirenz Empagliflozin Enoxaparin Epirubicin Eplerenone Epoprostenol Ertugliflozin Estramustine Ethacrynate Etodolac Everolimus Exenatide Fenoldopam Fenoprofen Fentanyl Ferric Carboxymaltose Ferric Derisomaltose Ferumoxytol Fludrocortisone Fluorescein Fluphenazine Flurazepam Flurbiprofen Furosemide Glimepiride Glipizide Glyburide Glycerin Guanfacine Haloperidol Heparin Hydrochlorothiazide Hydrocodone Hydrocortisone Hydroflumethiazide Hydromorphone Hydroxyzine Ibuprofen Icatibant Idelalisib Iloperidone Iloprost Imipramine Indapamide Indomethacin Insulin Degludec Insulin Detemir Insulin Glargine Insulin Lispro Interferon Beta-1a Interferon Beta-1b Iron Sucrose Isocarboxazid Isosorbide Dinitrate Ketoprofen Ketorolac Lanthanum Carbonate Levodopa Licorice Linagliptin Linezolid Lofexidine Lorazepam Loxapine Lumateperone Lurasidone Mannitol Maprotiline Maraviroc Meclofenamic Acid Mefenamate Meloxicam Meperidine Meprobamate Mesoridazine Metformin Methadone Methazolamide Methdilazine Methocarbamol Methotrexate Methotrimeprazine Methylprednisolone Metolazone Mirtazapine Molindone Morphine Nabilone Nabumetone Nalbuphine Naltrexone Naproxen Nateglinide Nefazodone Nesiritide Nitroglycerin Nortriptyline Olanzapine Oliceridine Olopatadine Opium Orphenadrine Oxaprozin Oxazepam Oxycodone Ozanimod Paliperidone Paraldehyde Pegaspargase Peginterferon Beta-1a Pentazocine Pentoxifylline Pergolide Perphenazine Phenelzine Phenobarbital Phenoxybenzamine Phenyl Salicylate Phenylbutazone Picosulfurate Piroxicam Polythiazide Prazosin Prednisolone Prednisone Pregabalin Procarbazine Prochlorperazine Promazine Promethazine Propiomazine Propoxyphene Pyrilamine Quazepam Quetiapine

Showing 240 of 446. Type above to find a specific drug.

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]MHRA (UK) · PL218800216 · revised December 19, 2025
[2]Health Canada (DPD) · 02479877 · revised November 27, 2025

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.